Physician

David D Lowenkron, M.D.,F.A.C.C.

According to 2025 Medicare claims, David Lowenkron, M.D., F.A.C.C. (NPI: 1063402261) practices cardiology in the Kiryas Joel-Poughkeepsie-Newburgh, NY market, with the plurality of this provider's patient population coming from Orange, NY. This provider's primary affiliated billing organization is MIDDLETOWN MEDICAL PC (NPI: 1902855828; TIN: 061127657) and primary practice location at 10940-2115. Lowenkron is affiliated with the The Accountable Care Organization, Ltd. (ACO ID: A2098), participating under the MSSP model.

Lowenkron's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,940 traditional Medicare patients, billed 9,609 HCPCS/CPT codes, and received $531,167 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 5,647 prescription claims across 752 beneficiaries totaling $881,266 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 5 records totaling $82. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $307,431 to $881,266. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,864	10,980	$530,174
2016	1,790	9,152	$524,815
2017	1,631	9,988	$553,268
2018	2,128	11,681	$630,284
2019	2,152	11,206	$538,643
2020	1,855	8,107	$475,148
2021	2,158	9,022	$563,275
2022	1,984	7,877	$463,420
2023	2,008	9,993	$612,151
2024	1,940	9,609	$531,167

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	482	3,631	$307,431
2016	512	3,929	$332,385
2017	570	4,280	$397,984
2018	613	4,582	$456,165
2019	617	4,445	$521,198
2020	591	4,714	$563,880
2021	646	4,857	$671,289
2022	649	5,259	$776,457
2023	723	5,402	$837,739
2024	752	5,647	$881,266

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	584	603	$133
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	595	1,453	$99
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	458	634	$13
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	432	497	$11
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	434	579	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	299	20,752	$394,331
Entresto	Sacubitril/Valsartan	78	5,370	$118,407
Xarelto	Rivaroxaban	64	5,520	$100,880
Multaq	Dronedarone Hcl	33	1,710	$43,145
Repatha Sureclick	Evolocumab	55	2,202	$41,282

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$82	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David D. Lowenkron, M.D., F.A.C.C.?

Tedicare shows public-source Medicare data for David D. Lowenkron, M.D., F.A.C.C. (NPI 1063402261), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David D. Lowenkron, M.D., F.A.C.C. have ACO affiliation data?

David D. Lowenkron, M.D., F.A.C.C. is shown with ACO affiliation data for The Accountable Care Organization, Ltd. (MSSP, ACO ID A2098).

What billing organization is linked to David D. Lowenkron, M.D., F.A.C.C.?

David D. Lowenkron, M.D., F.A.C.C. is linked to MIDDLETOWN MEDICAL PC (billing NPI 1902855828) in the available physician profile data.

Does David D. Lowenkron, M.D., F.A.C.C. have Open Payments data?

David D. Lowenkron, M.D., F.A.C.C. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.